LLY vs ZTS
By Alex · Tickerpine
Eli Lilly and Company vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | ZTS |
|---|---|---|
| Price | $1,220.28 | $73.54 |
| Market cap | $1.09T | $30.39B |
| P/E ratio | 41.0 | 12.3 |
| ROE | 102.29% | 64.91% |
| Profit margin | 33.53% | 27.68% |
| Revenue growth | 47.70% | -0.20% |
| Dividend yield | 0.57% | 2.81% |
| Beta | 0.51 | 0.73 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs ZTS in plain English
- LLY is the bigger company — about 35.8× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 12.3 vs 41.0).
- LLY earns a higher return on equity (102% vs 65%).
- LLY is growing revenue faster (48% vs -0%).
- ZTS has the higher dividend yield (2.81% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.